Sm14 Schistosoma mansoni Fatty Acid‐Binding Protein: Molecular Basis for an Antihelminth Vaccine
Authors:
- 18 July 2012
- book chapter
- Published by Wiley
- p. 435-449
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine AdjuvantPLOS ONE, 2011
- A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza VaccinesPLOS ONE, 2010
- In Vitro and In Vivo Activities of Arachidonic Acid against Schistosoma mansoni and Schistosoma haematobiumAntimicrobial Agents and Chemotherapy, 2010
- Parasites and poverty: The case of schistosomiasisActa Tropica, 2010
- Study of the local immune response to Fasciola hepatica in the liver and hepatic lymph nodes of goats immunised with a peptide of the Sm14 antigenResearch in Veterinary Science, 2009
- Current Status of Vaccines for SchistosomiasisClinical Microbiology Reviews, 2008
- Vaccination of buffaloes with Fasciola gigantica recombinant fatty acid binding proteinParasitology Research, 2005
- Expression and cross-species reactivity of fatty acid-binding protein of Clonorchis sinensisParasitology Research, 2004
- Immune Regulation by helminth parasites: cellular and molecular mechanismsNature Reviews Immunology, 2003
- The global burden of intestinal nematode infections — Fifty years onParasitology Today, 1997